ArticleKidney international2013

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Pietro Ravani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.